BHVN logo

BHVN EBITDA

Annual EBITDA

-$429.14 M
+$137.41 M+24.25%

December 31, 2023

Summary

Performance

1-Year Change

+24.25%

3-Year Change

-275.01%

5-Year Change

-87.84%

15-Year Change

-240.09%

BHVN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

2.57%
BHVN annual EBITDA is higher than 2.57% of companies in Healthcare sector

High & Low

All-time High

-$10.07 M

3-Year Low

-$566.55 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
BHVN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
BHVN next annual earnings announcement is scheduled for Feb 28, 2025

OtherBHVNprofitabilitymetrics:

Annual Revenue

-
BHVN annual revenue value is unknown

Annual Net Income

-$408.17 M
BHVN annual net profit is -$408.17 million

Annual EBIT

-$436.05 M
BHVN annual earnings before interest & taxes is -$436.05 million

Annual EPS

-$5.73
BHVN annual earnings per share is -$5.73

Quarterly EBITDA

-$176.17 M
+$155.64 M+46.91%

September 30, 2024

Summary

Performance

3-Month Change

+46.91%

1-Year Change

-16.04%

3-Year Change

+17.32%

5-Year Change

+17.32%

BHVN Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

0.85%
BHVN quarterly EBITDA is higher than 0.85% of companies in Healthcare sector

High & Low

All-time High

-$2.98 M

3-Year Low

-$331.82 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BHVN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
BHVN next earnings announcement is scheduled for Feb 28, 2025

OtherBHVNprofitabilitymetrics:

Quarterly Revenue

-
BHVN quarterly revenue value is unknown

Quarterly Net Income

-$160.30 M
BHVN quarterly net profit is -$160.30 million

Quarterly EBIT

-$178.17 M
BHVN quarterly earnings before interest & taxes is -$178.17 million

Quarterly EPS

-$1.70
BHVN quarterly earnings per share is -$1.70

TTM EBITDA

-$841.60 M
-$67.17 M-8.67%

September 30, 2024

Summary

Performance

3-Month Change

-8.67%

1-Year Change

-96.11%

3-Year Change

-48.55%

5-Year Change

-48.55%

BHVN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

0.59%
BHVN TTM EBITDA is higher than 0.59% of companies in Healthcare sector

High & Low

All-time High

-$2.98 M

3-Year Low

-$841.60 M
BHVN TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BHVN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
BHVN next earnings announcement is scheduled for Feb 28, 2025

OtherBHVNprofitabilitymetrics:

TTM Revenue

-
BHVN TTM revenue value is unknown

TTM Net Income

-$804.34 M
BHVN TTM net profit is -$804.34 million

TTM EBIT

-$848.89 M
BHVN TTM earnings before interest & taxes is -$848.89 million

TTM EPS

-$9.41
BHVN TTM earnings per share is -$9.41

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$429.14 M
BHVN annual EBITDA is -$429.14 million

Annual Net Income

-$408.17 M
BHVN annual net profit is -$408.17 million

Annual Interest Expense

-
BHVN annual interest expense value is unknown

Annual Income Tax

-$1.38 M
BHVN annual income tax is -$1.38 million

Annual D&A

$6.91 M
BHVN annual depreciation & amortization is $6.91 million

BHVN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+24.3%-16.0%-96.1%
3 y3 years-275.0%+17.3%-48.5%
5 y5 years-87.8%+17.3%-48.5%

BHVN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-97.3%+24.3%-251.0%+46.9%-698.0%at low
5 y5-year-275.0%+24.3%-251.0%+46.9%-698.0%at low
alltimeall time-4163.3%+24.3%-5802.0%+46.9%<-9999.0%at low

Biohaven Pharmaceutical Holding EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$176.17 M(-46.9%)
-$841.60 M(+8.7%)
Jun 2024
-
-$331.82 M(+82.5%)
-$774.44 M(+44.8%)
Mar 2024
-
-$181.79 M(+19.7%)
-$534.80 M(+24.6%)
Dec 2023
-$429.14 M(-24.3%)
-$151.82 M(+39.3%)
-$429.14 M(-12.5%)
Sep 2023
-
-$109.01 M(+18.3%)
-$490.39 M(+9.3%)
Jun 2023
-
-$92.18 M(+21.1%)
-$448.64 M(-18.9%)
Mar 2023
-
-$76.13 M(-64.3%)
-$553.16 M(-2.4%)
Dec 2022
-$566.55 M(+160.5%)
-$213.07 M(+216.8%)
-$566.55 M(+40.3%)
Sep 2022
-
-$67.26 M(-65.8%)
-$403.68 M(+3.1%)
Jun 2022
-
-$196.69 M(+119.7%)
-$391.68 M(+100.9%)
Mar 2022
-
-$89.52 M(+78.3%)
-$194.99 M(+84.9%)
Dec 2021
-$217.51 M(+90.1%)
-
-
Dec 2021
-
-$50.20 M(-9.2%)
-$105.46 M(-55.1%)
Sep 2021
-
-$55.27 M(-69.2%)
-$234.83 M(-64.6%)
Dec 2020
-$114.43 M(-76.6%)
-
-
Dec 2020
-
-$179.56 M(+8.4%)
-$663.44 M(+6.8%)
Sep 2020
-
-$165.69 M(+3.4%)
-$621.34 M(+13.0%)
Jun 2020
-
-$160.22 M(+1.4%)
-$549.80 M(-7.0%)
Mar 2020
-
-$157.97 M(+14.9%)
-$591.47 M(+21.0%)
Dec 2019
-$488.45 M
-
-
DateAnnualQuarterlyTTM
Dec 2019
-
-$137.45 M(+46.0%)
-$488.89 M(+22.1%)
Sep 2019
-
-$94.15 M(-53.4%)
-$400.40 M(+10.6%)
Jun 2019
-
-$201.90 M(+264.6%)
-$361.89 M(+82.1%)
Mar 2019
-
-$55.38 M(+13.1%)
-$198.73 M(-13.1%)
Dec 2018
-$228.46 M(+81.1%)
-
-
Dec 2018
-
-$48.96 M(-12.0%)
-$228.73 M(+10.3%)
Sep 2018
-
-$55.65 M(+43.6%)
-$207.39 M(+6.7%)
Jun 2018
-
-$38.74 M(-54.6%)
-$194.37 M(+0.6%)
Mar 2018
-
-$85.38 M(+209.0%)
-$193.30 M(+53.2%)
Dec 2017
-$126.18 M(+100.1%)
-
-
Dec 2017
-
-$27.63 M(-35.2%)
-$126.18 M(+2.1%)
Sep 2017
-
-$42.62 M(+13.1%)
-$123.64 M(+13.2%)
Jun 2017
-
-$37.68 M(+106.4%)
-$109.18 M(+39.4%)
Mar 2017
-
-$18.25 M(-27.2%)
-$78.32 M(+24.2%)
Dec 2016
-$63.06 M(+526.5%)
-
-
Dec 2016
-
-$25.09 M(-10.9%)
-$63.06 M(+66.1%)
Sep 2016
-
-$28.17 M(+313.1%)
-$37.97 M(+287.3%)
Jun 2016
-
-$6.82 M(+128.4%)
-$9.80 M(+228.4%)
Mar 2016
-
-$2.98 M
-$2.98 M
Dec 2015
-$10.07 M
-
-

FAQ

  • What is Biohaven Pharmaceutical Holding annual EBITDA?
  • What is the all time high annual EBITDA for Biohaven Pharmaceutical Holding?
  • What is Biohaven Pharmaceutical Holding annual EBITDA year-on-year change?
  • What is Biohaven Pharmaceutical Holding quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Biohaven Pharmaceutical Holding?
  • What is Biohaven Pharmaceutical Holding quarterly EBITDA year-on-year change?
  • What is Biohaven Pharmaceutical Holding TTM EBITDA?
  • What is the all time high TTM EBITDA for Biohaven Pharmaceutical Holding?
  • What is Biohaven Pharmaceutical Holding TTM EBITDA year-on-year change?

What is Biohaven Pharmaceutical Holding annual EBITDA?

The current annual EBITDA of BHVN is -$429.14 M

What is the all time high annual EBITDA for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high annual EBITDA is -$10.07 M

What is Biohaven Pharmaceutical Holding annual EBITDA year-on-year change?

Over the past year, BHVN annual EBITDA has changed by +$137.41 M (+24.25%)

What is Biohaven Pharmaceutical Holding quarterly EBITDA?

The current quarterly EBITDA of BHVN is -$176.17 M

What is the all time high quarterly EBITDA for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high quarterly EBITDA is -$2.98 M

What is Biohaven Pharmaceutical Holding quarterly EBITDA year-on-year change?

Over the past year, BHVN quarterly EBITDA has changed by -$24.36 M (-16.04%)

What is Biohaven Pharmaceutical Holding TTM EBITDA?

The current TTM EBITDA of BHVN is -$841.60 M

What is the all time high TTM EBITDA for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high TTM EBITDA is -$2.98 M

What is Biohaven Pharmaceutical Holding TTM EBITDA year-on-year change?

Over the past year, BHVN TTM EBITDA has changed by -$412.46 M (-96.11%)